ARTICLE | Company News
JNJ receives HCV license from Chiron
February 2, 2001 8:00 AM UTC
The R.W. Johnson Pharmaceutical Research Institute, a Johnson & Johnson (JNJ) company, received a non-exclusive license to develop small molecule therapeutics against a genomic hepatitis C virus (HCV)...